TLR2 and bacterial arthritis: For instance, certain TLR2 agonists or inhibitors have demonstrated the potential to modulate inflammatory responses through STAT3/SOCS3 signaling in a murine model of septic arthritis (Ghosh and Bishayi, 2024).